Medical and Pharmaceutical Daraxonrasib shrinks tumours in one-third of lung cancer patients Non-small-cell lung cancer accounts for most lung cancer diagnoses Joseph MortonSeptember 3, 2026
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan DunneAugust 28, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026